ASH 2022 | Major unmet needs in Ph+ ALL and future outlooks
Sabina Chiaretti
• 11 Dec 2022
Sabina Chiaretti, MD, PhD, Sapienza University of Rome, Rome, Italy, briefly discusses unmet needs in patients with relapsed/refractory (R/R) Philadelphia chromosome positive (Ph+) acute lymphoblastic leukemia (ALL), emphasizing the need to improve treatment strategies for these patients.This interview took place at the 64th ASH Annual Meeting and Exposition congress held in New Orleans, LA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
